K
Description
KBI Biopharma Inc. is an award-winning biopharmaceutical CDMO providing fully integrated, accelerated drug development and biomanufacturing services globally. With proven success in 200+ first-in-human programs, it specializes in mAbs, Fc-fusion proteins, multispecific antibodies, ADCs, and cell therapies. Its KBI SUREtechnology™ Platform (Selexis® SURE CHO-M) leads in cell line development. It serves 500+ customer partners with 170+ candidates in development and 11 commercial products.